Colossal Biosciences Acquires Pet Cloning Company to Advance De-Extinction Efforts
Colossal Biosciences, a “de-extinction” startup working to revive long-lost species such as the woolly mammoth, is acquiring a Texas-based company with an equally eye-catching mission: cloning pets. The deal marks Colossal’s first-ever acquisition and brings under its wings ViaGen, a venture specializing in reproducing deceased dogs, cats and horses. Its star-studded client list features Barbra…

